Illumina's Billion Cell Atlas Aims to Speed Drug Discovery with AI-powered Insights
TL;DR Summary
Illumina unveiled the Billion Cell Atlas, a massive dataset mapping how gene perturbations affect 200 cell lines to accelerate drug discovery via AI-powered models and virtual cells; with about 150 million cells generated so far and a goal of a billion by year-end, the company has signed on Merck, AstraZeneca, and Eli Lilly as initial customers.
Topics:business#artificial-intelligence#billion-cell-atlas#drug-discovery#genomics#illumina#technology
- Illumina launches massive cell atlas to fast-track drug discovery statnews.com
- Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery Illumina
- Illumina unveils dataset to speed up AI-powered drug discovery Reuters
- AstraZeneca (AZN) Joins in Groundbreaking Genetic Research Initiative GuruFocus
- Illumina Launches Cell Atlas to Map Billions of Cells for Drug Discovery geneonline.com
Reading Insights
Total Reads
0
Unique Readers
5
Time Saved
2 min
vs 3 min read
Condensed
88%
483 → 56 words
Want the full story? Read the original article
Read on statnews.com